Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Muscle Invasive”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT03421236
What this trial is testing

Intravesical Ty21a for the Treatment of Patients With Non-muscle-invasive Bladder Cancer (NMIBC)

Who this might be right for
Non Muscle Invasive Bladder Cancer
Patrice Jichlinski 25
Not applicableStudy completedNCT03697928
What this trial is testing

Markers of Carnitine Acetyltransferase (CrAT) Protein Activity and Carnitine Availability

Who this might be right for
Metabolism and Nutrition DisorderMetabolic Disturbance
Maastricht University 13
Testing effectiveness (Phase 2)Ended earlyNCT03747419
What this trial is testing

Avelumab and Radiation in Muscle-Invasive Bladder Cancer

Who this might be right for
Bladder CancerMuscle Invasive Bladder Cancer
Dana-Farber Cancer Institute 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06227065
What this trial is testing

Precise Chemoresection in Low-grade NMIBC Using Drug Screens in Patient-derived Organoids

Who this might be right for
Bladder CancerNon-muscle Invasive Bladder CancerLow Grade
Hospital Centre Biel/Bienne 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT05544552
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaSolid Tumor+11 more
Tyra Biosciences, Inc 310
Not applicableLooking for participantsNCT04900558
What this trial is testing

Robotic Radical Cystectomy Outcomes

Who this might be right for
Bladder CancerMuscle-Invasive Bladder CarcinomaOncology+2 more
University of Florence 500
Early research (Phase 1)Looking for participantsNCT06108492
What this trial is testing

A Phase I Clinical Study of SHR-2005 Intravesical Instillation in the Treatment of Intermediate and High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Who this might be right for
Intermediate and High-risk Non-muscle Invasive Bladder Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 170
Not applicableUnknownNCT05547516
What this trial is testing

Blue Laser -5ala Photodynamic Therapy (PDT) in High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

Who this might be right for
Non-muscle-invasive Bladder Cancer
First Affiliated Hospital Xi'an Jiaotong University 140
Not applicableEnded earlyNCT02202044
What this trial is testing

Sequential Intravesical Bacillus Calmette-Guérin and Electromotive Mitomycin-C After Transuretheral Resection

Who this might be right for
Bladder Carcinoma
University of Colorado, Denver 13
Not applicableLooking for participantsNCT07602010
What this trial is testing

Comparison of CT and MR (VI-RADS) Imaging for Local Bladder Cancer Staging

Who this might be right for
Bladder CancerUrothelial Carcinoma (UC)Muscle Invasive Bladder Cancer (MIBC)+1 more
Oslo University Hospital 150
Not applicableStudy completedNCT07402317
What this trial is testing

Trimodality Bladder Preservation

Who this might be right for
Bladder Cancer Treatment
Al-Azhar University 97
Testing effectiveness (Phase 2)Ended earlyNCT02030574
What this trial is testing

Neoadjuvant Gemcitabine and Fractionated, Weekly Cisplatin For Muscle Invasive Bladder Cancer and Patients Not Candidates For High Dose Cisplatin

Who this might be right for
Invasive Bladder CancerBladder Cancer
Brown University 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07625527
What this trial is testing

Is Prolonged Systemic Immunotherapy Necessary After Achieving Tumor-free Status in Patients With Extensive Transurethrally Unresectable Very-high-risk NMIBC?

Who this might be right for
Bladder (Urothelial, Transitional Cell) CancerNon Muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital 120
Large-scale testing (Phase 3)UnknownNCT04311073
What this trial is testing

Prophylactic Tranexamic Acid During Minimally Invasive Myomectomies

Who this might be right for
Fibroid UterusAbnormal Uterine BleedingMyoma;Uterus
Eastern Virginia Medical School 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07822373
What this trial is testing

Study Evaluating Bladder Preservation With Enfortumab Vedotin Plus Pembrolizumab in Patients With Muscle-Invasive Urothelial Cancer

Who this might be right for
Muscle-invasive Bladder Urothelial Carcinoma
University of Utah 25
Not applicableStudy completedNCT05946369
What this trial is testing

Neutrophils to Lymphocytes Ratio in Predicting the Response to BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Urinary Bladder CancerUrinary Bladder NeoplasmBCG+2 more
Ain Shams University 96
Testing effectiveness (Phase 2)Study completedNCT00837161
What this trial is testing

Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids

Who this might be right for
Uterine FibroidsUterine Leiomyomata
Philips Healthcare 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351
What this trial is testing

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 33
Testing effectiveness (Phase 2)UnknownNCT03950362
What this trial is testing

Bladder PREserVation by RadioTherapy and Immunotherapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
Institut Paoli-Calmettes 67
Testing effectiveness (Phase 2)UnknownNCT04101812
What this trial is testing

Pegylated Liposomal Doxorubicin, PD-1 in Treating Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
Tianjin Medical University Second Hospital 60
Next Page